Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDestiny Pharma. Share News (DEST)

Share Price Information for Destiny Pharma. (DEST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.25
Bid: 18.00
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 0.50 (2.778%)
Open: 18.25
High: 18.25
Low: 18.25
Prev. Close: 18.25
DEST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Mind Gym revenue recovers; Dispersion buys Accru

Mon, 18th Oct 2021 15:12

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Mind Gym PLC - London-based training and management development company - Expects revenue of GBP24.1 million in the six months ended September 30, up 66% year-on-year from GBP14.5 million. Revenue remained slightly above the GBP23.9 million reported in the comparative pre-Covid period, two years earlier. Says 82% of income was "digitally enabled". Continues to invest in its technological capacities ahead of the planned launches of its new digital products. Expects to release its interim results on December 3.

----------

Dispersion Holdings PLC - decentralised finance investor using blockchain and cryptocurrencies to remove financial intermediaries from transactions - Acquires Accru Finance Ltd for GBP8.8 million, to be paid via the issue of 250 million new company shares. Accru's sellers will then hold a 29% stake in Dispersion. The company says Accru plans to launch: "the first internationally-regulated and insured platform for the trading and yield farming of cryptocurrencies." Expects to approve the deal at the company's general meeting next Tuesday.

----------

IXICO PLC- AI data analytics company based in London - Reports revenue of GBP9.2 million in the year ended September 30, down 3.2% from GBP9.5 million a year prior but 5.7% above market expectations of GBP8.7 million. Expects earnings before interest, tax, depreciation and amortisation of GBP1.2 million, in line with market expectations but slightly below the GBP1.3 million taken a year earlier. Notes that this reflects the GBP7.1 million adverse impact of lost revenue from the end of its Huntington's Disease trial in March. Expects lower profitability in financial 2022 as the company invests in long-term sustained growth.

----------

7digital Group PLC - London-based music licensing provider - Secures GBP1 million expansion to revolving credit facility with Investec Bank. Brings total facility with Investec up to GBP2 million total. Says the enlarged facility matures in September 2023, in keeping with the original terms agreed with the bank in September 2020. Issues 5.4 million warrants with an excise price of 0.55 pence and a lifespan of 36 months, as an arrangement fee to Investec.

----------

Artisanal Spirits Co PLC - Edinburgh, Scotland-based owner of the Scotch Malt Whisky Society - Signs 10-year lease for a new supply chain facility in Uddingston, Scotland. Says the 37,000 square foot facility will provide the company with greater control over its supply chain, in order to improve its margins over time. It includes warehousing, production and office space, with equipment due to be installed in early 2022. The facility is scheduled to become fully operation in the second half of 2022, the company adds.

----------

Destiny Pharma PLC - Brighton, England-based clinical stage biotechnology company focused on life threatening infections - Says US hospital-based study supports potential of XF-73 nasal product to reduce intensive care unit infections. The phase 4 study includes 300,000 patients and shows 23% of all ICU infections are caused by the staphylococcus aureus bacteria. Proposes its XF-73 product as an alternative to mupirocin for these infections. Notes current regulatory talks concerning phase 3 studies to obtain marketing approval for XF-73 in the US and Europe.

----------

ReNeuron Group PLC - Bridgend, Wales-based exosome therapeutics company - Sees first subject treated at Oxford Eye Hospital in a Phase 2a RP trial of its therapeutic candidate for retinitis pigmentosa, a degenerative eye disease. The study uses 2 million cell doses on subjects with some remaining vision, despite having advanced retinitis pigmentosa. Appoints Catherine Isted as chief financial officer and executive director. Notes the departure of non-executive director Chris Evans as he approaches non-independent status after nine years on the board.

----------

Hemogenyx Pharmaceuticals PLC - London-based developer of drugs for blood diseases - Leases custom laboratory at the Mink Building in New York from The Janus Property Co. Says the new laboratory is close to Columbia University and City College, possibly easing future collaboration. The 10,000 square foot laboratory includes two purpose built clean rooms. The company says the new space will be used to pursue commercialisation of its major cell therapy product candidates by manufacturing cells in-house, starting with its HEMO-CAR-T treatment for acute myeloid leukemia.

----------

Corcel PLC - London-based mineral explorer and developer with interests in battery metals and flexible energy generation & storage - Acquires Wo Wo Gap Nickel-Cobalt project in Papua New Guinea. Says it acquired the project as it reached a share purchase agreement with Resource Mining Corp Ltd to acquire the entire issued share capital of the project's owner Niugini Nickel Pty Ltd. "Near term priorities at Wo Wo gap will include resource updates, exploring synergies with our Mambare project, and the early securing of long term shipping and offtake arrangements," says Corcel's executive chair James Parsons.

----------

IGas Energy PLC - Lincoln-based oil and gas producer - Agrees head of terms with Iona Capital Ltd to develop utility scale solar farms in the UK. Initially plans to develop a 25 to 40 megawatt solar farm in southern England, the first of several similar projects. "IGas will contribute its planning and infrastructure expertise, whilst Iona will provide non-recourse project finance. During the development phase, costs will be shared and throughout the project lifecycle, IGas and Iona will each own 50% of the project," the company says.

----------

Gem Diamonds Ltd - London-based miner - Recovers high quality Type 2, 245 carat Type 2 and 102 carat white diamonds. Says it uncovered the stones from the Letseng mine in Lesotho, "the highest dollar per carat kimberlite diamond mine in the world".

----------

Ethernity Networks Ltd - Networking and security solutions provider based in Israel - Secures USD3 million order with Chinese broadband network OEM. Says the order is for customised FPGA system-on-chip processors and covers 2022 and 2023. Expecs further orders thereafter. Under the terms of the agreement, the company will supply OEM with its system-on-chip devices with support for four Gigabit Passive Optical Networking Optical Line Termination ports and four 10Gbps XGS-PON OLT MAC ports by the second quarter of 2022. These products support OEM's 5G and fibre access developments.

----------

Castillo Copper Ltd - Australia and Zambia-focused base metal copper exploration company - Begins drilling at its Arya Copper Prospect in the Mount Isa region of Queensland, Australia. Says drilling follows a significant logistical effort to prepare the drill-pads, heli-lift and other equipment at the site. Plans to drill five initial holes as "proof of concept" at the Arya site and expects to expand the campaign to fully test the area. Focuses drilling on targets identified by BHP in the 1990s, including EG01, EG02 and EG101,2. Notes large a potential 130 metre-thick sulphide bedrock conductor at the EG01 target. Says initial observations are encouraging. Notes concurrent rock chip sampling campaign to extend the known surface anomaly to the south.

----------

React Group PLC - South Derbyshire, England-based cleaning, hygiene and decontamination firm - Wins GBP230,000 contract to provide specialist deep cleaning services for a rail sector client. The contract runs for 25-weeks through to the end of March 2022, the company adds. "Securing this contract highlights the quality and depth of work being provided by the specialist teams within the group and continues to strengthen our presence in the rail sector," says Chief Executive Shaun Doak.

----------

Home REIT PLC - London-based real estate investment trust - Spends GBP166.4 million on property pipeline. Acquires 23 portfolios including 366 properties across England and Wales. Funds the purchases with proceeds from its oversubscribed GBP350 million equity issue in September. Says its total property pipeline totals GBP400 million.

----------

By Scarlett Butler; scarlettbutler@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Apr 2024 20:57

TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Apr 2024 10:23

AIM WINNERS & LOSERS: Kromek jumps 14% on US government contract

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
31 Jan 2024 18:28

EARNINGS AND TRADING: STV raises holding in Two Cities Television

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
4 Jan 2024 14:07

Destiny Pharma seeks to capitalise on XF-73 market potential in 2024

(Alliance News) - Destiny Pharma PLC on Thursday said that its priority remains promoting its XF-73 Nasal antibacterial drug.

Read more
4 Jan 2024 11:27

Destiny Pharma reports progress on clinical assets

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma said in a year-end update on Thursday that its primary focus remained on realising the full potential of its XF-73 Nasal asset.

Read more
29 Oct 2023 21:01

Sunday share tips: Destiny Pharma, Invinity Energy Systems

(Sharecast News) - The Financial Mail on Sunday's Midas column spied long-term potential in Destiny Pharma's shares.

Read more
17 Oct 2023 11:15

Destiny Pharma celebrates study findings on "potent" flagship drug

(Alliance News) - Destiny Pharma PLC shares soared on Tuesday after new data showed XF-73, its leading antibacterial drug, to be effective against over 2,500 Staphylococcus isolates, including resistant strains.

Read more
17 Oct 2023 10:18

AIM WINNERS & LOSERS: Destiny Pharma posts "landmark" XF-73 data

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
20 Sep 2023 14:27

TRADING UPDATES: Dianomi swings to loss; Epwin revenue up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
13 Sep 2023 15:48

UK earnings, trading statements calendar - next 7 days

Thursday 14 September 
Arecor Therapeutics PLCHalf Year Results
Brooks Macdonald Group PLCFull Year Results
Capricorn Energy PLCHalf Year Results
Checkit PLCHalf Year Results
Churchill China PLCHalf Year Results
Foresight Solar Fund LtdHalf Year Results
Glenveagh Properties PLCHalf Year Results
IG Group Holdings PLCTrading Statement
Keystone Law Group PLCHalf Year Results
Kier Group PLCFull Year Results
M&C Saatchi PLCHalf Year Results
MJ Gleeson PLCFull Year Results
Oakley Capital Investments LtdHalf Year Results
Renishaw PLCFull Year Results
Spire Healthcare Group PLCHalf Year Results
THG PLCHalf Year Results
Trainline PLCTrading Statement
Uniphar PLCHalf Year Results
Friday 15 September 
Petra Diamonds LtdFull Year Results
VH Global Sustainable Energy Opportunities PLCHalf Year Results
Monday 18 September 
Artisanal Spirits Co PLCHalf Year Results
City of London Investment Group PLCFull Year Results
Downing Renewables & Infrastructure Trust PLCHalf Year Results
Facilities by ADF PLCHalf Year Results
Futura Medical PLCHalf Year Results
Greencoat Renewables PLCHalf Year Results
HgCapital Trust PLCHalf Year Results
Phoenix Group Holdings PLCHalf Year Results
S4 Capital PLCHalf Year Results
Tuesday 19 September 
accesso Technology Group PLCHalf Year Results
Billington Holdings PLCHalf Year Results
Big Technologies PLCHalf Year Results
C&C Group PLCTrading Statement
Concurrent Technologies PLCHalf Year Results
CPPGroup PLCHalf Year Results
Eagle Eye Solutions Group PLCFull Year Results
Fintel PLCHalf Year Results
Good Energy Group PLCHalf Year Results
Hargreaves Lansdown PLCFull Year Results
Henry Boot PLCHalf Year Results
Kingfisher PLCHalf Year Results
Litigation Capital Management LtdFull Year Results
Maintel Holdings PLCHalf Year Results
McBride PLCFull Year Results
MyHealthChecked PLCHalf Year Results
Moonpig Group PLCTrading Statement
Naked Wines PLCFull Year Results
Northcoders Group PLCHalf Year Results
Ocado Group PLCTrading Statement
Serica Energy PLCHalf Year Results
SThree PLCTrading Statement
Surgical Innovations Group PLCHalf Year Results
Team17 Group PLCHalf Year Results
Trustpilot Group PLCHalf Year Results
Water Intelligence PLCHalf Year Results
Xaar PLCHalf Year Results
Wednesday 20 September 
Advanced Medical Solutions Group PLCHalf Year Results
ASA International Group PLCHalf Year Results
Destiny Pharma PLCHalf Year Results
Dunelm Group PLCTrading Statement
Epwin Group PLCHalf Year Results
Galliford Try Holdings PLCFull Year Results
GENinCode PLCHalf Year Results
HydrogenOne Capital Growth PLCHalf Year Results
Judges Scientific PLCHalf Year Results
LBG Media PLCHalf Year Results
M&G PLCHalf Year Results
Oxford Biomedica PLCHalf Year Results
PYX Resources LtdHalf Year Results
Round Hill Music Royalty Fund LtdHalf Year Results
Supermarket Income REIT PLCFull Year Results
Ten Entertainment Group PLCHalf Year Results
Warpaint London PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
31 Jul 2023 17:31

TRADING UPDATES: MGC Pharmaceuticals granted psilocybin import permit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
25 Jul 2023 14:27

IN BRIEF: Destiny Pharma says former Chair Nigel Rudd return to role

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Says Nigel Rudd will be returning as chair, effective immediately. He was chair of Destiny from 2010 to 2018, and led its flotation on the London AIM market.

Read more
19 Jul 2023 13:16

IN BRIEF: Destiny Pharma appoints Chris Tovey as CEO; Chair resigns

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Appoints Chris Tovey as chief executive officer from September 1, taking over from Interim CEO Debra Barker who will return to position of non-executive director. The company announces departure of Chair Nick Rodgers, expects to announce new outside chair shortly.

Read more
6 Jul 2023 12:49

IN BRIEF: Destiny Pharma confirms phase 3 development for lead asset

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Confirms proposed phase three development pathway and identifies new life cycle management targets for its XF-73 Nasal programme. Says antimicrobial properties of XF-73 Nasal give greater flexibility in the scheduling of surgeries. Adds there is potential to explore new life management indications, particularly in children.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.